arrow
A

Ali Darwich

Ruprecht-Karls University Heidelberg
H指数:9
被引数:267

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Primary CD34+ cells of patients with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome are highly sensitive to targeted treatment with TAK-243

具有空泡的E1酶、X连锁、自身炎症性、体细胞(VEXAS)综合征患者的外周CD34+细胞对TAK-243靶向治疗高度敏感。

2025-10-120
OAAI
The bispecific innate cell engager AFM28 eliminates CD123+ leukemic stem and progenitor cells in AML and MDS

双特异性先天细胞连接器AFM28消除AML和MDS中CD123+白血病干细胞和祖细胞

2025-08-210
OA
Primary Hematopoietic Cells of Vexas Patients Are Highly Sensitive to Treatment with TAK-243 and Pevonedistat

Vexas患者的原发性造血细胞对TAK-243和Pevonedistat治疗高度敏感

BLOOD
IF23.1
2024-11-050
PRE
ASXL1 mutations are associated with a response to alvocidib and 5-azacytidine combination in myelodysplastic neoplasms
2023-11-022
OAAI
Significant improvement of bone marrow-derived MSC expansion from MDS patients by defined xeno-free medium
2023-06-075
OAAI
Inhibition of lysyl oxidases synergizes with 5-azacytidine to restore erythropoiesis in myelodysplastic and myeloid malignancies
2023-03-175
OAAI
Preclinical evaluation of eltrombopag in a PDX model of myelodysplastic syndromes
LEUKEMIA
IF13.4
2021-06-258
OAAI